Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Post by ValueCapon Jun 17, 2019 5:00pm
148 Views
Post# 29833259

Certainly no bankruptcy. And some more good news

Certainly no bankruptcy. And some more good newsCost synergies to save 7 million. Blexten growing at 72% over last year in high allergy season. Cambia up 33%. 

Deerfield allowing for deferral mechanism at Nuvo’s discretion if Vimovo US loses exclusivity 

Stock looks cheap at $.92 here 

https://nuvopharmaceuticals.mediaroom.com/2019-06-17-Nuvo-Pharmaceuticals-TM-Provides-Corporate-Update
<< Previous
Bullboard Posts
Next >>